...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Question on valuing shares from time of spinoff

bfw - If memory serves correct ZEL was said to be about 9% of RVX. Personally I gave it a zero value at the time(as it is pretty much unimportant in Canada) and I am carrying it with a zero cost base. So in my case 100% of any sale price would be a capital gain. This is only important for non registered accounts in Canada.

tada

5
Sep 13, 2018 08:08AM
1
Sep 13, 2018 09:28AM
2
Sep 13, 2018 11:34AM
Share
New Message
Please login to post a reply